Xlife Sciences AG (XLS)

Currency in CHF
21.70
+0.30(+1.40%)
Closed·
XLS Scorecard
Full Analysis
Trading at a high revenue valuation multiple
XLS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
21.2023.00
52 wk Range
16.5535.90
Key Statistics
Bid/Ask
21.30 / 23.00
Prev. Close
21.4
Open
23
Day's Range
21.2-23
52 wk Range
16.55-35.9
Volume
1.28K
Average Volume (3m)
2.18K
1-Year Change
-37.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XLS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Profitable over the last twelve months

Xlife Sciences AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Xlife Sciences AG Company Profile

Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients for human and veterinary medicines; and offers clinical research organization services. In addition, the company builds a bridge between research/ development and healthcare markets, as well as support researchers and entrepreneurs in the positioning, structuring, development, and implementation of their ideas; and operates as an active ingredient manufacturer. Further, it focuses on identifying innovative biomarkers in the field of kidney diseases; the development of antibody-drug conjugates through a click chemistry approach and microfluidic screening of functional antibodies; and provides Neuromex, a screening instrument for the early-stage detection of neurological diseases. Xlife Sciences AG was founded in 2019 and is headquartered in Zurich, Switzerland.

Compare XLS to Peers and Sector

Metrics to compare
XLS
Peers
Sector
Relationship
P/E Ratio
3.6x5.4x−0.5x
PEG Ratio
0.030.330.00
Price/Book
0.4x2.5x2.6x
Price / LTM Sales
149.2x4.2x3.3x
Upside (Analyst Target)
-34.0%43.4%
Fair Value Upside
Unlock11.2%7.1%Unlock

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
4.46 / --
Revenue / Forecast
485.06K / --
EPS Revisions
Last 90 days

XLS Income Statement

FAQ

What Stock Exchange Does Xlife Sciences Trade On?

Xlife Sciences is listed and trades on the Switzerland Stock Exchange stock exchange.

What Is the Stock Symbol for Xlife Sciences?

The stock symbol for Xlife Sciences is "XLS."

What Is the Xlife Sciences Market Cap?

As of today, Xlife Sciences market cap is 124.60M.

What Is Xlife Sciences's Earnings Per Share (TTM)?

The Xlife Sciences EPS (TTM) is 6.00.

From a Technical Analysis Perspective, Is XLS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Xlife Sciences Stock Split?

Xlife Sciences has split 0 times.

How Many Employees Does Xlife Sciences Have?

Xlife Sciences has 17 employees.

What is the current trading status of Xlife Sciences (XLS)?

As of 10 Aug 2025, Xlife Sciences (XLS) is trading at a price of 21.70, with a previous close of 21.40. The stock has fluctuated within a day range of 21.20 to 23.00, while its 52-week range spans from 16.55 to 35.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.